Vitreous body affects activation and maturation of monocytes into macrophages

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 234, Issue 10, 1996, Pages 637-642

  Osuský, Roman ^a,c   Walker, Sharyn M ^a,b   Ryan, Steven J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY EYE CLINIC   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; HYALURONIC ACID; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; BIOASSAY; CELL ACTIVITY; CELL CULTURE; CELL MATURATION; CELL SIZE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; EYE DISEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; VITREOUS BODY;

EID: 0029838766     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00185298     Document Type: Article

References (26)

1. Akiyama Y, Griffith R, Miller P, Stevenson GW, Lund S, Kanapa DJ, Stevenson HC (1988) Effects of adherence, activation, and distinct serum proteins on the in vitro human monocyte maturation process. J Leukoc Biol 43: 224-231
2. Balazs EA, Denlinger JL (1984) The vitreous. In: Davson H (ed) The Eye, Academic Press, Orlando, pp 533-589
3. Boer JH de, Limpens J, Orengo-Nania S, Jong PTVM de, Heij EL, Kijlstra A (1994) Low mature TGF-b2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci 35: 3702-3710
4. Charteris DG, Hiscott P, Robey HL, Gregor ZJ, Lightman SL, Grierson I (1993) Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. Ophthalmology 100: 43-46
5. Connor TB Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, Bustros S de, Enger C, Kato H, Lansing M, Hayashi H, Glaser BM (1989) Correlation of fibrosis and transforming growth factor beta type 2 levels in the eye. J Clin Invest 83: 1661-1666
6. Derynck R (1994) Transforming growth factor beta. In: Thomson A (ed) The cytokine handbook. Harcourt Brace, London, pp 319-432
7. Eisenstein R, Grant-Bertacchini D (1991) Growth inhibitory activities in avascular tissues are recognized by anti-transforming growth factor beta antibodies. Curr Eye Res 10: 157-162
8. Ennist DL, Jones KH (1983) Rapid method for identification of macrophages in suspension by acid alpha-naphthyl acetate esterase activity. J Histochem Cytochem 31: 960-963
9. Fukuda N, Kubo A, Izumi Y, Soma M, Kanmatsuse K (1995) Characteristics and expression of transforming growth factor-beta receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 13: 831-837
10. Furth R van (1992) Production and migration of monocytes and kinetics of macrophages. In: Furth R van (ed) Mononuclear phagocytes: biology of monocytes and macrophages. Kluwer, Dordrecht, pp 3-12
11. Gloor BP (1972) Zur Frage der Beteiligung der Glaskörperrindenzellen bei experimenteller Uveitis. Mod Probl Ophthalmol 10: 41-48
12. Hirokawa M, Gray JD, Takahashi T, Horwitz DA (1992) Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation. J Immunol 149: 1859-1866
13. Hofman FM, Wright AD, Dohadwala MM, Wong-Staal F, Walker SM (1993) Exogenous fat protein activates human endothelial cells. Blood 82: 2774-2780
14. Keller JR, Bartelmez SH, Sitnicka E, Ruscetti FW, Ortiz M, Gooya JM, Jacobsen SE (1994) Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth. Blood 84: 2175-2181
15. Kirchhof B, Sorgente N (1989) Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages. Dev Ophthalmol 16: 1-53
16. Leibovich SJ, Ross R (1975) The role of macrophage in wound repair: a study with hydrocortisone and anti-macrophase serum. Am J Pathol 78: 71-99
17. Limb GA, Little BC, Meager A, Ogilvie JA, Wolstencroft RA, Franks WA, Chignell AH, Dumonde DC (1991) Cytokines in proliferative vitreoretinopathy. Eye 5: 686-693
18. Nakagawara A, Nathan CF, Cohn ZA (1981) Hydrogen peroxide metabolism in human monocytes during differentiation in vitro. J Clin Invest 68: 1243-1252
19. Pepper MS, Vassalli JD, Orci L, Montesano R (1993) Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res 204: 356-363
20. Ruppert J, Peters H (1991) IL-6 and IL-1 enhance the accessory activity of human blood monocytes during differentiation to macrophages. J Immunol 146: 144-149
21. Sandberg N (1964) Time relationship between administration of cortisone and wound healing in rats Acta Chir Scand 127: 446-455
22. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699
23. Streilein JW (1987) Immune regulation and the eye: a dangerous compromise. FASEB J 1: 199-208
24. Tang S, Scheiffarth OF, Wildner G, Thurau SR, Lund OE (1992) Lymphocytes, macrophages and HLA-DR expression in vitreal and epiretinal membranes of proliferative vitreoretinopathy. An immunohistochemical study. Ger J Ophthalmol 1: 176-179
25. Van Damme J, Van Beeumen J, Decock B, Van Snick J, De Ley M, Biliau A (1988) Separation and comparision of two monokines with lymphocyte activating factor activity (interleukin-1 beta and hybridoma growth factor): identification of leucocyte derived HGF as interleukin-6. J Immunol 140: 1534-1541
26. Young E, Lutty GA (1987) Modulation of human lymphocyte proliferation by normal bovine vitreous. Invest Ophthalmol Vis Sci 28: 753-756